A Study to Compare the Efficacy and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Lymphoma | Non-Hodgkin
Age: Between 18 - 75 Years
Gender: Male or Female
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required